Ohio Public Employees Retirement System (OPERS)’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,666
Closed -$178K 2416
2024
Q4
$178K Hold
9,666
﹤0.01% 1693
2024
Q3
$334K Hold
9,666
﹤0.01% 1479
2024
Q2
$283K Hold
9,666
﹤0.01% 1329
2024
Q1
$546K Buy
9,666
+3,488
+56% +$154K ﹤0.01% 1244
2023
Q4
$265K Hold
6,178
﹤0.01% 1342
2023
Q3
$214K Hold
6,178
﹤0.01% 1353
2023
Q2
$287K Hold
6,178
﹤0.01% 1348
2023
Q1
$285K Hold
6,178
﹤0.01% 1350
2022
Q4
$499K Sell
6,178
-1,402
-18% -$97.4K ﹤0.01% 1281
2022
Q3
$421K Hold
7,580
﹤0.01% 1355
2022
Q2
$395K Buy
7,580
+3,563
+89% +$199K ﹤0.01% 1373
2022
Q1
$330K Buy
+4,017
New +$382K ﹤0.01% 1405
2021
Q1
Sell
-639
Closed -$139K 2005
2020
Q4
$139K Hold
639
﹤0.01% 1509
2020
Q3
$64K Hold
639
﹤0.01% 1625
2020
Q2
$50K Hold
639
﹤0.01% 1705
2020
Q1
$65K Buy
639
+131
+26% +$13.8K ﹤0.01% 1524
2019
Q4
$56K Hold
508
﹤0.01% 1722
2019
Q3
$46K Hold
508
﹤0.01% 1845
2019
Q2
$58K Hold
508
﹤0.01% 1794
2019
Q1
$58K Buy
+508
New +$52.8K ﹤0.01% 1782

Other funds holding STRO

Ohio Public Employees Retirement System (OPERS)'s STRO Position: Q1 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Sutro Biopharma (STRO) in Q1 2025, closing a stake of 9,666 shares — an estimated $178K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in STRO in Q1 2019 and held it in 20 quarters. The position peaked at $546K in Q1 2024. 112 funds tracked by Wall St. Rank hold STRO as of Q1 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Sutro Biopharma position as of Q1 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 9,666 Sutro Biopharma shares in Q1 2025, an estimated $178K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Sutro Biopharma in Q1 2019 and held it in 20 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Sutro Biopharma position peaked at $546K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2025, filed 14 May 2025.